FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4230885554> ?p ?o ?g. }

• W4230885554 abstract "Background Poisoning with carbon monoxide (CO) remains an important cause of accidental and intentional injury worldwide. Several unblinded nonrandomized trials have suggested that the use of hyperbaric oxygen (HBO) prevents the development of neurological sequelae. This has led to the widespread use of HBO in the management of patients with carbon monoxide poisoning. Objectives To assess the effectiveness of hyperbaric oxygen (HBO) compared to normobaric oxygen (NBO) for the prevention of neurologic symptoms in patients with acute carbon monoxide poisoning. Search methods We searched MEDLINE (1966‐present), EMBASE (1980‐present), and the Controlled Trials Register of the Cochrane Collaboration, supplemented by a manual review of bibliographies of identified articles and discussion with recognized content experts. Selection criteria All randomized controlled trials involving non pregnant adults acutely poisoned with carbon monoxide, regardless of severity, with adequate or unclear allocation concealment were examined. Trials with a score of 3 out of 5 or higher on the validity instrument of Jadad were included in the primary analysis. Data collection and analysis Two reviewers independently extracted from each trial information on the number of randomized patients, types of participants, the dose and duration of the intervention, and the prevalence of neurologic symptoms at follow‐up. A pooled odds ratio (OR) for the presence of neurologic symptoms at one month follow‐up was calculated using a random effects model. Main results Six randomized controlled trials were identified. The trials were of varying quality. Three trials employing different doses of NBO and HBO were included in the primary analysis. The severity of CO poisoning was inconsistent between trials. At one month follow‐up after treatment, symptoms possibly related to carbon monoxide poisoning were present in 81 of 237 patients (34.2%) treated with HBO, compared with 81 of 218 patients (37.2%) treated with NBO (O.R. for benefit with HBO 0.82; 95% CI 0.41‐1.66). Authors' conclusions There is no evidence that unselected use of HBO in the treatment of acute CO poisoning reduces the frequency of neurological symptoms at one month. However, evidence from the available randomized controlled trials is insufficient to provide clear guidelines for practice. Further research is needed to better define the role of HBO, if any, in the treatment of carbon monoxide poisoning. This research question is ideally suited to a multicentre, randomized, double‐blind controlled trial." @default.
• W4230885554 created "2022-05-11" @default.
• W4230885554 creator A5068763296 @default.
• W4230885554 creator A5084113951 @default.
• W4230885554 creator A5084189800 @default.
• W4230885554 date "2000-04-24" @default.
• W4230885554 modified "2023-10-12" @default.
• W4230885554 title "Hyperbaric oxygen for carbon monoxide poisoning" @default.
• W4230885554 cites W1986215651 @default.
• W4230885554 cites W2062923878 @default.
• W4230885554 cites W2068297497 @default.
• W4230885554 cites W2141195554 @default.
• W4230885554 cites W2143861549 @default.
• W4230885554 cites W2396479144 @default.
• W4230885554 cites W4214559180 @default.
• W4230885554 doi "https://doi.org/10.1002/14651858.cd002041" @default.
• W4230885554 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10796853" @default.
• W4230885554 hasPublicationYear "2000" @default.
• W4230885554 type Work @default.
• W4230885554 citedByCount "16" @default.
• W4230885554 countsByYear W42308855542014 @default.
• W4230885554 countsByYear W42308855542015 @default.
• W4230885554 countsByYear W42308855542018 @default.
• W4230885554 countsByYear W42308855542019 @default.
• W4230885554 crossrefType "reference-entry" @default.
• W4230885554 hasAuthorship W4230885554A5068763296 @default.
• W4230885554 hasAuthorship W4230885554A5084113951 @default.
• W4230885554 hasAuthorship W4230885554A5084189800 @default.
• W4230885554 hasConcept C126322002 @default.
• W4230885554 hasConcept C136524200 @default.
• W4230885554 hasConcept C141071460 @default.
• W4230885554 hasConcept C156957248 @default.
• W4230885554 hasConcept C168563851 @default.
• W4230885554 hasConcept C1862650 @default.
• W4230885554 hasConcept C194828623 @default.
• W4230885554 hasConcept C2776478404 @default.
• W4230885554 hasConcept C2781119925 @default.
• W4230885554 hasConcept C3017944768 @default.
• W4230885554 hasConcept C71924100 @default.
• W4230885554 hasConceptScore W4230885554C126322002 @default.
• W4230885554 hasConceptScore W4230885554C136524200 @default.
• W4230885554 hasConceptScore W4230885554C141071460 @default.
• W4230885554 hasConceptScore W4230885554C156957248 @default.
• W4230885554 hasConceptScore W4230885554C168563851 @default.
• W4230885554 hasConceptScore W4230885554C1862650 @default.
• W4230885554 hasConceptScore W4230885554C194828623 @default.
• W4230885554 hasConceptScore W4230885554C2776478404 @default.
• W4230885554 hasConceptScore W4230885554C2781119925 @default.
• W4230885554 hasConceptScore W4230885554C3017944768 @default.
• W4230885554 hasConceptScore W4230885554C71924100 @default.
• W4230885554 hasLocation W42308855541 @default.
• W4230885554 hasLocation W42308855542 @default.
• W4230885554 hasOpenAccess W4230885554 @default.
• W4230885554 hasPrimaryLocation W42308855541 @default.
• W4230885554 hasRelatedWork W2016627623 @default.
• W4230885554 hasRelatedWork W2019846923 @default.
• W4230885554 hasRelatedWork W2045568211 @default.
• W4230885554 hasRelatedWork W2080020162 @default.
• W4230885554 hasRelatedWork W2171823549 @default.
• W4230885554 hasRelatedWork W2374506814 @default.
• W4230885554 hasRelatedWork W2381217328 @default.
• W4230885554 hasRelatedWork W2381297747 @default.
• W4230885554 hasRelatedWork W2386434209 @default.
• W4230885554 hasRelatedWork W2996173115 @default.
• W4230885554 isParatext "false" @default.
• W4230885554 isRetracted "false" @default.
• W4230885554 workType "reference-entry" @default.